Truist Securities Reiterates Buy on Laboratory Corp, Maintains $270 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Ryan MacDonald has reiterated a 'Buy' rating on Laboratory Corp (NYSE:LH) and maintained a price target of $270.
September 15, 2023 | 3:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has reiterated a 'Buy' rating on Laboratory Corp and maintained a price target of $270.
The reaffirmation of a 'Buy' rating by Truist Securities indicates a positive outlook for Laboratory Corp. The maintained price target of $270 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100